27 February 2018 - - The Upper Nyack, New York-based non-profit organization Global Healthy Living Foundation (GHLF) stands with the FDA and its Commissioner Dr. Scott Gottlieb in promoting biosimilars as a safe, effective and potentially less expensive way to improve and sustain the quality of life for people living with otherwise debilitating chronic conditions, as well as for shorter-term cancer treatments, the organization said.
GHLF and its arthritis community, CreakyJoints, strongly disagrees with last week's public statement from the Patients for Biologics Safety and Access chiding the FDA for its efforts to educate providers about the critical role biosimilars play in healthcare.
Because of escalating premiums, deductibles and copays, patients are paying more for their healthcare. Biosimilars, and biologics that are competitively priced, offer one way to reduce these costs to patients without reducing effectiveness or safety.
GHLF believes that in addition to passing on the savings to patients that the decision to switch any medication should be a decision made between the patient and physician.
GHLF's mission is to improve the quality of life for people living with chronic illnesses, such as arthritis, osteoporosis, migraine, diabetes, psoriasis, and cardiovascular disease by advocating for improved access to care at the community, state, and federal levels, and amplifying education and awareness efforts within its social media framework. It is also a staunch advocate for vaccines.
GHLF is the parent organization of CreakyJoints, which provides education, support, advocacy and patient-centered research through ArthritisPower, a research registry for joint, bone, and inflammatory skin conditions.